Document is current
Any future updates will be listed below
-
Authors
Gao, Jing
Liu, Yang
Si, Chenfang
Guo, Rui
Hou, Shouqiao
Liu, Xiaosong
Long, Houfang
Liu, Di
Xu, Daichao https://orcid.org/0000-0002-3286-4968
Zhang, Zai-Rong
Liu, Cong https://orcid.org/0000-0003-3425-6672
Shan, Bing https://orcid.org/0000-0003-4178-3526
Turck, Christoph W.
He, Kaiwen https://orcid.org/0000-0002-1187-098X
Zhang, Yaoyang https://orcid.org/0000-0001-5363-9834
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32071245)
Natural Science Foundation of Shanghai (20ZR1474400)
Science and Technology Commission of Shanghai Municipality (2019SHZDZX02)
Shanghai Basic Research Pioneer Project Shanghai Key Laboratory of Aging Studies
- License Information
-
More Information
Article History
Received: 13 April 2023
Accepted: 28 January 2025
First Online: 7 February 2025
Competing interests
: Y.Z., J.G. and K.H. have filed a patent application related to the use of aspirin or its derivatives for treating diseases associated with abnormal aggregation of α-syn. All other authors declare no competing interests.
: All animal experimental procedures were reviewed and approved by the Institutional Animal Care and Use Committee at the Interdisciplinary Research Center on Biology and Chemistry, Chinese Academy of Sciences, and are in accordance with the Guide for the Care and Use of Laboratory Animals of the Chinese Academy of Sciences.
